Douglas E. Wood M.D., F.A.C.S., F.R.C.S.Ed.

 Douglas  E. Wood M.D., F.A.C.S., F.R.C.S.Ed.

Bio

"Dr. Wood is a UW professor, chief of the Division of Cardiothoracic Surgery and the endowed chair in lung cancer research. He is a world-renowned surgeon…

Read Full Bio

Patient Care Philosophy

I try to take care of each patient as if he or she were a member of my own family. I strongly believe that prompt and efficient evaluation and clear explanations help patients make good decisions. Our goal is that every cancer patient will have a work-up completed and a treatment plan defined within a few days of his or her first phone call to our office.

Personal Interests

Dr. Wood enjoys traveling with his family. He is an avid photographer, downhill and water skier, and likes to run and lift weights to keep fit. He has aspirations to become skilled in kite boarding, but has not quite mastered it yet.

Clinical Interests

Thoracic oncology (lung, esophageal, mediastinal and chest wall tumors), benign and malignant airway disease and emphysema surgery.

Research Interests

Thoracic oncology, tracheobronchial pathology, as well as, surgery and endobronchial therapies for emphysema.

Dr. Wood leads the multi-disciplinary thoracic oncology team at the University of Washington and Seattle Cancer Care Alliance, who are involved in a wide variety of clinical trials for lung and esophageal cancer. He holds the UW Endowed Chair in Lung Cancer Research and is the author of over 200 articles and book chapters.

Dr. Wood developed one of the early programs in lung volume reduction surgery (LVRS) for severe emphysema, initiating the program at UW in 1994. He was a major participant in the National Emphysema Treatment Trial (NETT) for which he was a co–principal investigator and wrote the surgical protocols for Medicare and the National Institutes of Health. The Agency for Health Research and Quality also sponsored a cost-effectiveness analysis of LVRS within the treatment trial, the largest cost-effectiveness study ever performed in a clinical study. He was the primary NETT clinician involved in the cost-effectiveness study; he subsequently worked directly with the Centers for Medicare and Medicaid Services (CMS) officials in developing the national coverage determinations for LVRS and the site selection criteria.

Education

InstitutionCredentialYear
Harvard Medical SchoolMedical education1983
Massachusetts General HospitalFellowship
Massachusetts General HospitalInternship
Massachusetts General HospitalResidency

DegreeDescriptionYear
MD1983

Board Certifications

CertificationSpecialtyYear
American Board of Thoracic SurgeryThoracic Surgery1993
American Board of SurgerySurgery1990
"Dr. Wood is a UW professor, chief of the Division of Cardiothoracic Surgery and the endowed chair in lung cancer research. He is a world-renowned surgeon in thoracic oncology, specializing in the areas of lung and esophageal cancer. He is also a national and international leader in the management of complex airway disease and in the surgical management of end-stage lung disease. He focuses his practice in these areas where he has led the UW thoracic group to be the leading referral center for patients from all over the Pacific Northwest.

Dr. Wood received his undergraduate and medical degrees from Harvard University and trained in general surgery and cardiothoracic surgery at the Massachusetts General Hospital in Boston. He then was recruited to Seattle to lead a new section of general thoracic surgery at the UW.

The thoracic surgery group at UW has grown to be the largest and most comprehensive practice in the Western United States, with patients traveling from all over the Pacific Northwest and beyond for the expertise in cancer surgery and end-stage lung disease offered by Dr. Wood and his team. Dr. Wood leads the multidisciplinary Thoracic Oncology Program where patients can get comprehensive evaluation and care from a dedicated team of pulmonary physicians, thoracic surgeons, medical oncologists and radiation oncologists. Patients with end-stage lung disease have options of lung volume reduction surgery, clinical trials of endobronchial valve therapy, pulmonary thromboendarterectomy or lung transplantation - the only lung transplant program in the Pacific Northwest, led by world expert, Dr. Michael Mulligan.

Dr. Wood is a world leader in thoracic surgery and thoracic oncology. He is the chair of the National Comprehensive Cancer Network (NCCN) Lung Cancer Screening Panel, the vice-chair of the NCCN Non-Small Cell Lung Cancer Panel, past director of the American Board of Thoracic Surgery, and past chair of the Accreditation Council for Graduate Medical Education Thoracic Surgery Residency Review Committee. Dr. Wood has been elected as the president of the Seattle Surgical Society, president of the Western Thoracic Surgical Association and president of the Society of Thoracic Surgeons. He is a Fellow of the American College of Surgeons, holds an honorary Fellowship ad hominem from the Royal College of Surgeons of Edinburgh, honorary memberships in the Society of Cardiothoracic Surgeons of Great Britain and Ireland and La Sociedad Mexicana de Cirujanos Torácicos Generales and has been a visiting professor at over 40 institutions worldwide. "

Provider Locations